Menu
Back to Journals » International Journal of Nanomedicine » Volume 18
Combined Biomimetic MOF-RVG15 Nanoformulation Efficient Over BBB for Effective Anti-Glioblastoma in Mice Model [Corrigendum]
Wu H, Liu Y, Chen L, et al. Int J Nanomedicine. 2022;17:6377–6398.
The authors have advised there is an error in Figure 8A on page 6392. Due to an error that occurred inadvertently at the time of figure assembly, the images of the fluorescence intensity of RVG15-PEG@IR-820@ZIF-8 at the 8 h are incorrect. The correct Figure 8 is as follows
Figure 8 Continued. Figure 8 Biodistribution of free IR-820, IR-820@ZIF-8, and RVG15-PEG@IR-820@ZIF-8 in vivo. (A) In vivo fluorescence imaging of orthotopic glioma-bearing mice treated with free IR-820, IR-820@ZIF-8, and RVG15-PEG@IR-820@ZIF-8 at 1, 4, 8, and 24 h. (B) Ex vivo fluorescence images of the excised brains and major organs at 24 h after injection. (C) Quantitative region-of-interest analysis of (B). Means ± SD, n = 3; *P < 0.05.
The authors wish to apologize for this error and advise it does not affect the interpretation of the data and the conclusion of the study.
© 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.